Wednesday, 24 July 2013

Genetic screening


DNA genetic testing and genetic screening involve the same testing processes to confirm or refute a suspected DNA change
-Tissues tested include blood, skin, saliva and hair follicles and, prenatally, embryo, placental tissue and amniotic fluid; DNA can be tested using blood 
-Genetic screening is done for a particular condition in individuals, groups or populations without family history of the condition
-Genetic testing is done for a particular condition where an individual is suspected of being at increased risk due to their family 
history or the result of a genetic screening test 
-Direct gene testing looks at the presence or absence of a known gene mutation by examining the sequence of letters in the information in the gene 
-The test is very accurate and used for diagnosis and screening including prenatal, genetic carrier testing and screening, presymptomatic and predictive testing 
Limitations include: 

 *Interpretation of the test result eg. finding that a person has a faulty gene does not always relate to how a person is, or will be, affected by that condition
 *The testing may be time-consuming and expensive for the health service if not for the patient 
 *For some complex conditions eg. cancer, the testing may have to be done on a family member with the condition to identify a family-specific mutation in the gene (mutation searching) before unaffected family members can be offered predictive testing 

-Indirect gene tracking (linkage) relies on comparing DNA markers from family members with the condition to markers in unaffected relatives 
-Used in situations where the gene itself has not been precisely located or where mutation(s) in a gene have not yet been defined; 
-the test is not as accurate as direct gene testing but can be used in diagnosis including prenatal and presymptomatic and predictive testing. 
-It may not always be possible to find DNA markers that enable the scientists to tell the difference between the faulty gene copy and the working gene copy .

KiteTM Mosquito Patch

KiteTM Mosquito Patch marked the begining of new war against mosquitos in "invisible way".It is the technology that hampers mosquitoes’ host-seeking behavior, identified at the University of California, Riverside in 2011, has led to the development of the world’s first product that blocks mosquitoes’ ability to efficiently detect carbon dioxide, their primary method of tracking human blood meals.
The initial research was performed in the laboratory of Anandasankar Ray, an associate professor of entomology, and was featured on the cover of the journal Nature.  Ray’s lab identified volatile odor molecules that can impair, if not completely disrupt, mosquitoes’ carbon dioxide detection machinery.
The intellectual property was licensed to Olfactor Laboratories Inc., a company that grew around the technology, expanded the research, filed additional patents, and developed related technologies that led to the mosquito-warding product.
Called the KiteTM Mosquito Patch, the product marks a significant advancement in the global fight against mosquito-borne diseases such as malaria, West Nile virus and dengue fever.  The patch delivers mosquito-repelling compounds in a simple, affordable and scalable sticker that can be used by individuals in regions impacted by malaria and other mosquito-borne diseases.